DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Long-term Behavior Change - 1

Information source: Friends Research Institute, Inc.
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Amphetamine-related Disorders

Intervention: contingency management voucher (Behavioral)

Phase: N/A

Status: Completed

Sponsored by: John Roll

Official(s) and/or principal investigator(s):
John Roll, Ph.D., Principal Investigator, Affiliation: University of California, Los Angeles

Summary

The purpose of this study is to determine if different reinforcement procedures (i. e., schedules) produce different patterns of long-term abstinence from methamphetamine. We anticipate that the three contingency management conditions will promote longer periods of abstinence in the year following treatment relative to the standard control group. Furthermore, we predict that the intermittent reinforcement procedures will produce longer periods of continued abstinence (i. e., long-term behavior change) in the year following treatment than the continuous reinforcement procedure. Finally, we predict that the intermittent unpredictable schedule will produce longer lasting behavior change than the intermittent predictable schedule. Methamphetamine use will be measured using urine toxicology and self-report of methamphetamine use.

Clinical Details

Official title: Behavior Change: Reinforcement Schedule Effects

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome:

Methamphetamine Use During Intervention

Methamphetamine Use, Measured by Number of Consecutive Days of Abstinence

Methamphetamine Use, Follow-Up

Detailed description: Briefly the four study conditions are: (1) standard treatment which consists of 16 weeks of psychosocial treatment, (2) continuous contingency management which consists of 16 weeks of psychosocial treatment with a contingency management procedure in effect during the first twelve weeks in which vouchers are made available after each provision of a methamphetamine-negative urine test, (3) intermittent predictable contingency management which consists of 16 weeks of psychosocial treatment with a contingency management procedure in effect during the first twelve weeks in which vouchers are available after the provision of every three consecutive methamphetamine-negative urine samples, and (4) intermittent unpredictable contingency management which consists of 16 weeks of psychosocial treatment with a contingency management procedure in effect during the first twelve weeks in which vouchers are available on one day each week (randomly selected after the first week) for the provision of methamphetamine-negative urine samples provided all urine samples since delivery of the last reinforcer were also methamphetamine negative.

Eligibility

Minimum age: 18 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Meet Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for

methamphetamine dependence

- Willing and able to comply with study procedures

- Willing and able to provide written informed consent

Exclusion Criteria:

- Have a medical condition that, in the study Principal Investigator (PI's) judgment,

might interfere with safe study participation

- Have a recent (past 30 days) history of suicide attempts and/or current serious

suicidal intention or plan as assessed by the Beck Depression Inventory (BDI)

- Have a history of violent criminal behavior or be on parole

- Any other circumstances that, in the opinion of the PI, would interfere with safe

study participation

Locations and Contacts

Friends Research Institute, Los Angeles, California 90025, United States

Friends Research Institute, Rancho Cucamonga, California 91730, United States

Additional Information

Starting date: December 2004
Last updated: June 30, 2014

Page last updated: August 20, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017